NVCR
Price
$16.45
Change
-$0.27 (-1.61%)
Updated
Jun 5 closing price
Capitalization
1.66B
48 days until earnings call
RVTY
Price
$90.50
Change
-$1.90 (-2.06%)
Updated
Jun 5 closing price
Capitalization
12.76B
59 days until earnings call
Interact to see
Advertisement

NVCR vs RVTY

Header iconNVCR vs RVTY Comparison
Open Charts NVCR vs RVTYBanner chart's image
NovoCure
Price$16.45
Change-$0.27 (-1.61%)
Volume$1.24M
Capitalization1.66B
Revvity
Price$90.50
Change-$1.90 (-2.06%)
Volume$777.07K
Capitalization12.76B
NVCR vs RVTY Comparison Chart
Loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCR vs. RVTY commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a StrongBuy and RVTY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (NVCR: $16.44 vs. RVTY: $90.50)
Brand notoriety: NVCR and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVCR: 117% vs. RVTY: 59%
Market capitalization -- NVCR: $1.66B vs. RVTY: $12.76B
NVCR [@Medical Specialties] is valued at $1.66B. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • NVCR’s FA Score: 1 green, 4 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCR is a better buy in the long-term than RVTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 4 TA indicator(s) are bullish while RVTY’s TA Score has 3 bullish TA indicator(s).

  • NVCR’s TA Score: 4 bullish, 5 bearish.
  • RVTY’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RVTY is a better buy in the short-term than NVCR.

Price Growth

NVCR (@Medical Specialties) experienced а -15.26% price change this week, while RVTY (@Medical Specialties) price change was -1.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.32%. For the same industry, the average monthly price growth was +4.56%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

NVCR is expected to report earnings on Jul 24, 2025.

RVTY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than NVCR($1.66B). RVTY YTD gains are higher at: -18.806 vs. NVCR (-44.832). RVTY has higher annual earnings (EBITDA): 714M vs. NVCR (-177.45M). RVTY has more cash in the bank: 1.6B vs. NVCR (911M). NVCR has less debt than RVTY: NVCR (596M) vs RVTY (4.07B). RVTY has higher revenues than NVCR: RVTY (2.75B) vs NVCR (509M).
NVCRRVTYNVCR / RVTY
Capitalization1.66B12.8B13%
EBITDA-177.45M714M-25%
Gain YTD-44.832-18.806238%
P/E RatioN/A71.72-
Revenue509M2.75B19%
Total Cash911M1.6B57%
Total Debt596M4.07B15%
FUNDAMENTALS RATINGS
NVCR vs RVTY: Fundamental Ratings
NVCR
RVTY
OUTLOOK RATING
1..100
143
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9485
PRICE GROWTH RATING
1..100
8463
P/E GROWTH RATING
1..100
994
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (59) in the Medical Specialties industry is somewhat better than the same rating for NVCR (100). This means that RVTY’s stock grew somewhat faster than NVCR’s over the last 12 months.

RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that RVTY’s stock grew similarly to NVCR’s over the last 12 months.

RVTY's SMR Rating (85) in the Medical Specialties industry is in the same range as NVCR (94). This means that RVTY’s stock grew similarly to NVCR’s over the last 12 months.

RVTY's Price Growth Rating (63) in the Medical Specialties industry is in the same range as NVCR (84). This means that RVTY’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (9) in the Medical Specialties industry is significantly better than the same rating for RVTY (94). This means that NVCR’s stock grew significantly faster than RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRRVTY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLDG24.770.10
+0.39%
Cambria Global Real Estate ETF
UTWO48.24-0.05
-0.11%
US Treasury 2 Year Note ETF
VO272.13-0.35
-0.13%
Vanguard Mid-Cap ETF
DFAR23.53-0.04
-0.17%
Dimensional US Real Estate ETF
AESR17.96-0.09
-0.50%
Anfield US Equity Sector Rotation ETF

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with TWST. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-1.67%
TWST - NVCR
41%
Loosely correlated
-0.36%
RVTY - NVCR
40%
Loosely correlated
-2.06%
A - NVCR
39%
Loosely correlated
-0.87%
BLFS - NVCR
38%
Loosely correlated
-2.41%
ALGN - NVCR
38%
Loosely correlated
+0.20%
More